Technology company Leidos is pouring $10 million into a plan to use AI to detect and manage diseases.
The company is working with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE) on a five-year plan to develop AI-powered tools for faster detection of diseases, including heart disease and cancer, as well as reduced diagnostic turnaround times, allowing...
Five digital health startups recently graduated from the accelerator programme of the National University of Singapore Yong Loo Lin School of Medicine and 22Health Ventures. Started as a hackathon event, the NUS Medicine Digital Advanced Technology Accelerator (DATA) supports startups to quickly scale their solutions for improving patient outcomes and clinician productivity.
"It's truly exciting...
California-based Capstan Medical, maker of robotic-enabled tools for heart valve disease, closed an oversubscribed $110 million Series C round led by Eclipse.
Existing investors Intuitive Ventures, Yu Galaxy, and new investor Gideon Strategic Partners, participated in the round.
WHAT IT DOES
The company offers surgical robotics with catheter-based technology and implants to repair and replace...
Cardiovascular imaging company Cleerly announced it raised $106 million in a Series C funding round.
The round was led by Insight Partners and Battery Ventures, with participation from preexisting investors.
WHAT IT DOES
Cleerly is a digital healthcare company that offers heart disease-diagnosis solutions. It developed a standard for coronary artery disease by integrating quality clinical...
ASX-listed Echo IQ has obtained regulatory approval in the United States for its AI-driven solution that supports structural heart disease diagnosis.
WHAT IT'S ABOUT
Two years since coming to the US, the company has now received 510(k) clearance from the Food and Drug Administration for EchoSolv AS, which is specifically indicated to support the diagnosis of severe aortic stenosis (a form of...
A research team from the Li Ka Shing Faculty of Medicine of the University of Hong Kong has developed an AI-powered mobile application that turns smartphones into a stethoscope to spot symptoms of heart diseases.
HOW IT WORKS
Called Vitogram, the app uses AI to analyse heart sounds, which are collected by placing the mobile phone on a user's chest.
"Analysing heart sounds provides important...
ICT tech provider Fujitsu and the University of Tokyo Hospital in Japan have teamed up to develop an artificial intelligence tool for the early detection of heart diseases.
The partners announced on Monday that starting 25 October, they will enter a clinical research phase to verify the effectiveness of the technology in estimating abnormal heart movements based on electrocardiogram data.
WHAT IT...
A team of researchers at the University of Western Australia is coming up with an artificial intelligence-based risk assessment tool to better detect plaque in heart computed tomography scans.
WHY IT MATTERS
The research team comprising AI and cardiac imaging experts was recently awarded a grant worth AU$896,606 (about $695,000) from the government's Medical Research Future Fund to develop a tool...
As mobile health technology continues to become ubiquitous, it can be a helpful management tool for older adults with existing heart disease, according to the American Heart Association.
The AHA conducted a systematic review of studies of older adults who used mobile health technologies to manage their cardiovascular disease. It included 26 studies that examined mobile health technologies for...
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes.
So of course it’s little surprise that cardiovascular health and care...
.jpg?itok=_Bq5miTs)
